Fenoldopam mesylate

Research use only, not for human use.

Fenoldopam is a selective dopamine-1 receptor (DA1) agonist with natriuretic/diuretic properties. It lowers blood pressure through arteriolar vasodilation.

Fenoldopam mesylate is a synthetic benzazepine derivative which acts as a selective D1 receptor partial agonist. Fenoldopam is used as an antihypertensive agent. It was approved by the Food and Drug Administration (FDA) in September 1997. Since fenoldopam is the only intravenous agent that improves renal perfusion, in theory it could be beneficial in hypertensive patients with concomitant renal insufficiency.

Fenoldopam, Corlopam, SK and F-82526J

Others

Other Targets

dopamine-1 receptor

Cardiovascular Disease

——

67227-57-0

401.86

C16H16ClNO3·CH4O3S

98%

DMSO : ≥ 36 mg/mL 89.58 mM; H2O : 10 mg/mL24.88 mM;

CS(O)(=O)=O.OC1=CC=C(C=C1)C1CNCCC2=C(Cl)C(O)=C(O)C=C12

9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol

(-20℃)

With Ice Pack

≥ 2 years